A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated salmonella vaccine strains

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3148-3162

  Wang, Shifeng ^a   Shi, Huoying ^a,c   Li, Yuhua ^a   Shi, Zhaoxing ^a   Zhang, Xin ^b   Baek, Chang Ho ^a   Mothershead, Tabor ^a   Curtiss, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; COLANIC ACID; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR SECRETION; CONTROLLED STUDY; CYTOKINE RESPONSE; DELETION MUTANT; FEMALE; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; OPERON; PRIORITY JOURNAL; SALMONELLA;

EID: 84884312622     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00097-13     Document Type: Article

References (106)

1. Grant WD, Sutherland IW, Wilkinson JF. 1969. Exopolysaccharide colanic acid and its occurrence in the Enterobacteriaceae. J. Bacteriol. 100:1187-1193.
2. Roberts IS. 1996. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 50:285-315.
3. Garegg PJ, Lindberg B, Onn T, Sutherland IW. 1971. Comparative structural studies on the M-antigen from Salmonella typhimurium, Escherichia coli and Aerobacter cloacae. Acta Chem. Scand. 25:2103-2108.
4. Stevenson G, Lan R, Reeves PR. 2000. The colanic acid gene cluster of Salmonella enterica has a complex history. FEMS Microbiol. Lett. 191:11-16.
5. Whitfield C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75:39-68.
6. Stevenson G, Andrianopoulos K, Hobbs M, Reeves PR. 1996. Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J. Bacteriol. 178:4885-4893.
7. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856.
8. Ionescu M, Belkin S. 2009. Overproduction of exopolysaccharides by an Escherichia coli K-12 rpoS mutant in response to osmotic stress. Appl. Environ. Microbiol. 75:483-492.
9. Chen MH, Takeda S, Yamada H, Ishii Y, Yamashino T, Mizuno T. 2001. Characterization of the RcsC→YojN→RcsB phosphorelay signaling pathway involved in capsular synthesis in Escherichia coli. Biosci. Biotechnol. Biochem. 65:2364-2367.
10. Gottesman S, Stout V. 1991. Regulation of capsular polysaccharide synthesis in Escherichia coli K12. Mol. Microbiol. 5:1599-1606.
11. Stout V. 1994. Regulation of capsule synthesis includes interactions of the RcsC/RcsB regulatory pair. Res. Microbiol. 145:389-392.
12. Takeda S, Fujisawa Y, Matsubara M, Aiba H, Mizuno T. 2001. A novel feature of the multistep phosphorelay in Escherichia coli: a revised model of the RcsC → YojN → RcsB signalling pathway implicated in capsular synthesis and swarming behaviour. Mol. Microbiol. 40:440-450.
13. García-Calderón CB, García-Quintanilla M, Casadesús J, Ramos-Morales F. 2005. Virulence attenuation in Salmonella enterica rcsC mutants with constitutive activation of the Rcs system. Microbiology 151:579-588.
14. Majdalani N, Gottesman S. 2005. The Rcs phosphorelay: a complex signal transduction system. Annu. Rev. Microbiol. 59:379-405.
15. Navasa N, Rodríguez-Aparicio L, Martínez-Blanco H, Arcos M, Ferrero MA. 2009. Temperature has reciprocal effects on colanic acid and polysialic acid biosynthesis in E. coli K92. Appl. Microbiol. Biotechnol. 82:721-729.
16. Reid AN, Whitfield C. 2005. Functional analysis of conserved gene products involved in assembly of Escherichia coli capsules and exopolysaccharides: evidence for molecular recognition between Wza and Wzc for colanic acid biosynthesis. J. Bacteriol. 187:5470-5481.
17. Danese PN, Pratt LA, Kolter R. 2000. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J. Bacteriol. 182:3593-3596.
18. Chen J, Lee SM, Mao Y. 2004. Protective effect of exopolysaccharide colanic acid of Escherichia coli O157:H7 to osmotic and oxidative stress. Int. J. Food Microbiol. 93:281-286.
19. Prigent-Combaret C, Lejeune P. 1999. Monitoring gene expression in biofilms. Methods Enzymol. 310:56-79.
20. Ophir T, Gutnick DL. 1994. A role for exopolysaccharides in the protection of microorganisms from desiccation. Appl. Environ. Microbiol. 60:740-745.
21. Sailer FC, Meberg BM, Young KD. 2003. β-Lactam induction of colanic acid gene expression in Escherichia coli. FEMS Microbiol. Lett. 226:245-249.
22. Laubacher ME, Ades SE. 2008. The Rcs phosphorelay is a cell envelope stress response activated by peptidoglycan stress and contributes to intrinsic antibiotic resistance. J. Bacteriol. 190:2065-2074.
23. Stout V. 1996. Identification of the promoter region for the colanic acid polysaccharide biosynthetic genes in Escherichia coli K-12. J. Bacteriol. 178:4273-4280.
24. Sledjeski DD, Gottesman S. 1996. Osmotic shock induction of capsule synthesis in Escherichia coli K-12. J. Bacteriol. 178:1204-1206.
25. Ebel W, Vaughn GJ, Peters HK, Trempy JE, III. 1997. Inactivation of mdoH leads to increased expression of colanic acid capsular polysaccharide in Escherichia coli. J. Bacteriol. 179:6858-6861.
26. Mao Y, Doyle MP, Chen J. 2001. Insertion mutagenesis of wca reduces acid and heat tolerance of enterohemorrhagic Escherichia coli O157:H7. J. Bacteriol. 183:3811-3815.
27. Lee SM, Chen J. 2004. Survival of Escherichia coli O157:H7 in set yogurt as influenced by the production of an exopolysaccharide, colanic acid. J. Food Prot. 67:252-255.
28. Pontel LB, Pezza A, Soncini FC. 2010. Copper stress targets the Rcs system to induce multiaggregative behavior in a copper-sensitive Salmonella strain. J. Bacteriol. 192:6287-6290.
29. Ferrières L, Clarke DJ. 2003. The RcsC sensor kinase is required for normal biofilm formation in Escherichia coli K-12 and controls the expression of a regulon in response to growth on a solid surface. Mol. Microbiol. 50:1665-1682.
30. Prigent-Combaret C, Vidal O, Dorel C, Lejeune P. 1999. Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J. Bacteriol. 181:5993-6002.
31. Prigent-Combaret C, Prensier G, Le Thi TT, Vidal O, Lejeune P, Dorel C. 2000. Developmental pathway for biofilm formation in curliproducing Escherichia coli strains: role of flagella, curli and colanic acid. Environ. Microbiol. 2:450-464.
32. Wang Q, Zhao Y, McClelland M, Harshey RM. 2007. The RcsCDB signaling system and swarming motility in Salmonella enterica serovar Typhimurium: dual regulation of flagellar and SPI-2 virulence genes. J. Bacteriol. 189:8447-8457.
33. Hanna A, Berg M, Stout V, Razatos A. 2003. Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli. Appl. Environ. Microbiol. 69:4474-4481.
34. Meredith TC, Mamat U, Kaczynski Z, Lindner B, Holst O, Woodard RW. 2007. Modification of lipopolysaccharide with colanic acid (Mantigen) repeats in Escherichia coli. J. Biol. Chem. 282:7790-7798.
35. Russo TA, Sharma G, Weiss J, Brown C. 1995. The construction and characterization of colanic acid-deficient mutants in an extraintestinal isolate of Escherichia coli (O4/K54/H5). Microb. Pathog. 18:269-278.
36. Mao Y, Doyle MP, Chen J. 2006. Role of colanic acid exopolysaccharide in the survival of enterohaemorrhagic Escherichia coli O157:H7 in simulated gastrointestinal fluids. Lett. Appl. Microbiol. 42:642-647.
37. Landau E, Shapira R. 2012. Effects of subinhibitory concentrations of menthol on adaptation, morphological, and gene expression changes in enterohemorrhagic Escherichia coli. Appl. Environ. Microbiol. 78:5361-5367.
38. Chao Y, Zhang T. 2011. Probing roles of lipopolysaccharide, type 1 fimbria, and colanic acid in the attachment of Escherichia coli strains on inert surfaces. Langmuir 27:11545-11553.
39. May T, Okabe S. 2008. Escherichia coli harboring a natural IncF conjugative F plasmid develops complex mature biofilms by stimulating synthesis of colanic acid and curli. J. Bacteriol. 190:7479-7490.
40. Lopez-Torres AJ, Stout V. 1996. Role of colanic acid polysaccharide in serum resistance in vivo and in adherence. Curr. Microbiol. 33:383-389.
41. Keenleyside WJ, Bronner D, Jann K, Jann B, Whitfield C. 1993. Coexpression of colanic acid and serotype-specific capsular polysaccharides in Escherichia coli strains with group II K antigens. J. Bacteriol. 175:6725-6730.
42. Navasa N, Rodriguez-Aparicio LB, Ferrero MA, Moteagudo-Mera A, Martinez-Blanco H. 2011. Growth temperature regulation of some genes that define the superficial capsular carbohydrate composition of Escherichia coli K92. FEMS Microbiol. Lett. 320:135-141.
43. Russo TA, Singh G. 1993. An extraintestinal, pathogenic isolate of Escherichia coli (O4/K54/H5) can produce a group 1 capsule which is divergently regulated from its constitutively produced group 2, K54 capsular polysaccharide. J. Bacteriol. 175:7617-7623.
44. Rahn A, Whitfield C. 2003. Transcriptional organization and regulation of the Escherichia coli K30 group 1 capsule biosynthesis (cps) gene cluster. Mol. Microbiol. 47:1045-1060.
45. Matthysse AG, Deora R, Mishra M, Torres AG. 2008. Polysaccharides cellulose, poly-β-1,6-N-acetyl-D-glucosamine, and colanic acid are required for optimal binding of Escherichia coli O157:H7 strains to alfalfa sprouts and K-12 strains to plastic but not for binding to epithelial cells. Appl. Environ. Microbiol. 74:2384-2390.
46. Prouty AM, Gunn JS. 2003. Comparative analysis of Salmonella enterica serovar Typhimurium biofilm formation on gallstones and on glass. Infect. Immun. 71:7154-7158.
47. Ledeboer NA, Jones BD. 2005. Exopolysaccharide sugars contribute to biofilm formation by Salmonella enterica serovar Typhimurium on HEp-2 cells and chicken intestinal epithelium. J. Bacteriol. 187:3214-3226.
48. Wang TK, Yam WC, Yuen KY, Wong SS. 2006. Misidentification of a mucoid strain of Salmonella enterica serotype Choleraesuis as Hafnia alvei by the Vitek GNI+ card system. J. Clin. Microbiol. 44:4605-4608.
49. Guard-Petter J. 1999. Phage type and other outer-membrane characteristics associate with virulence. In Saeed A, Gast RK, Potter ME, Wall PG (ed), Salmonella enterica serovar Enteritidis in humans and animals: epidemiology, pathogenesis, and control. Iowa State University Press, Ames, IA.
50. Hagiwara D, Sugiura M, Oshima T, Mori H, Aiba H, Yamashino T, Mizuno T. 2003. Genome-wide analyses revealing a signaling network of the RcsC-YojN-RcsB phosphorelay system in Escherichia coli. J. Bacteriol. 185:5735-5746.
51. Sung BH, Lee CH, Yu BJ, Lee JH, Lee JY, Kim MS, Blattner FR, Kim SC. 2006. Development of a biofilm production-deficient Escherichia coli strain as a host for biotechnological applications. Appl. Environ. Microbiol. 72:3336-3342.
52. Curtiss R, III, Wanda SY, Gunn BM, Zhang X, Tinge SA, Ananthnarayan V, Mo H, Wang S, Kong W. 2009. Salmonella enterica serovar Typhimurium strains with regulated delayed attenuation in vivo. Infect. Immun. 77:1071-1082.
53. Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda SY, Roland KL, Curtiss R, III. 2009. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl. Acad. Sci. U. S. A. 106:593-598.
54. Shi H, Santander J, Brenneman KE, Wanda SY, Wang S, Senechal P, Sun W, Roland KL, Curtiss R, III. 2010. Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen. PLoS One 5:e11142. doi:10.1371/journal.pone.0011142.
55. Shi H, Wang S, Roland KL, Gunn BM, Curtiss R, III. 2010. Immunogenicity of a live recombinant Salmonella enterica serovar Typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers. Clin. Vaccine Immunol. 17:363-371.
56. Bollen WS, Gunn BM, Mo H, Lay MK, Curtiss R, III. 2008. Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect. Immun. 76:3268-3272.
57. Markovitz A, Sydiskis RJ, Lieberman MM. 1967. Genetic and biochemical studies on mannose-negative mutants that are deficient in phosphomannose isomerase in Escherichia coli K-12. J. Bacteriol. 94:1492-1496.
58. Rosen SM, Zeleznick LD, Fraenkel D, Wiener IM, Osborn MJ, Horecker BL. 1965. Characterization of the cell wall lipopolysaccharide of a mutant of Salmonella typhimurium lacking phosphomannose isomerase. Biochem. Z. 342:375-386.
59. Curtiss R, III, Xin W, Li Y, Kong W, Wanda SY, Gunn B, Wang S. 2010. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit. Rev. Immunol. 30:255-270.
60. Collins LV, Attridge S, Hackett J. 1991. Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice. Infect. Immun. 59:1079-1085.
61. Curtiss R, III, Zhang X, Wanda SY, Kang HY, Konjufca V, Li Y, Gunn B, Wang S, Scarpellini G, Lee IS. 2007. Induction of host immune responses using Salmonella-vectored vaccines, p 297-313. In Brogden KA, Minion FC, Cornick N, Stanton TB, Zhang Q, Nolan LK, Wannemuehler MJ (ed), Virulence mechanisms of bacterial pathogens, 4th ed. ASM Press, Washington, DC.
62. Kuehn MJ, Kesty NC. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19:2645-2655.
63. Alaniz RC, Deatherage BL, Lara JC, Cookson BT. 2007. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179:7692-7701.
64. Nnalue NA. 1999. All accessible epitopes in the Salmonella lipopolysaccharide core are associated with branch residues. Infect. Immun. 67:998-1003.
65. Stanislavsky ES, Makarenko TA, Kholodkova EV, Lugowski C. 1997. R-form lipopolysaccharides (LPS) of Gram-negative bacteria as possible vaccine antigens. FEMS Immunol. Med. Microbiol. 18:139-145.
66. Jansson PE, Lindberg AA, Lindberg B, Wollin R. 1981. Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae. Eur. J. Biochem. 115:571-577.
67. Lüderitz O, Westphal O, Staub AM, Nikaido H. 1971. Isolation and chemical and immunological characterization of bacterial lipopolysaccharides, p 145-223. In Weinbaum G, Kadis S, Ajl S (ed), Microbial toxins, vol 4. Bacterial endotoxins. Academic Press, Inc., New York, NY.
68. Curtiss R, III, Pereira DA, Hsu JC, Hull SC, Clark JE, Maturin LJ, Sr Goldschmidt R, Moody R, Inoue M, Alexander L. 1977. Biological containment: the subordination of Escherichia coli K-12, p 45-56. In Roland Beers F, Bassett EG (ed), Recombinant molecules: impact on science and society. Raven Press, New York, NY.
69. Kong W, Wanda SY, Zhang X, Bollen W, Tinge SA, Roland KL, Curtiss R, III. 2008. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc. Natl. Acad. Sci. U. S. A. 105:9361-9366.
70. Baek CH, Wang S, Roland KL, Curtiss R, III. 2009. Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium. J. Bacteriol. 191:1278-1292.
71. Curtiss R, III, Porter SB, Munson M, Tinge SA, Hassan JO, Gentry-Weeks C, Kelly SM. 1991. Nonrecombinant and recombinant avirulent Salmonella live vaccines for poultry, p 169-198. In Blankenship LC, Bailey JH.S, Cox N.A, Stern NJ, Meinersmann RJ (ed), Colonization control of human bacterial enteropathogens in poultry. Academic Press, New York, NY.
72. Bertani G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
73. Hitchcock PJ, Brown TM. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
74. Wang S, Li Y, Shi H, Scarpellini G, Torres-Escobar A, Roland KL, Curtiss R, III. 2010. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine. Infect. Immun. 78:3258-3271.
75. Briles DE, King JD, Gray MA, McDaniel LS, Swiatlo E, Benton KA. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14:858-867.
76. Wang S, Li Y, Scarpellini G, Kong W, Shi H, Baek CH, Gunn B, Wanda SY, Roland KL, Zhang X, Senechal-Willis P, Curtiss R, III. 2010. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect. Immun. 78:3969-3980.
77. Wang S, Li Y, Shi H, Sun W, Roland KL, Curtiss R, III. 2011. Comparison of a regulated delayed antigen synthesis system with in vivoinducible promoters for antigen delivery by live attenuated Salmonella vaccines. Infect. Immun. 79:937-949.
78. Sedgwick JD, Holt PG. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57:301-309.
79. Whitfield C, Paiment A. 2003. Biosynthesis and assembly of group 1 capsular polysaccharides in Escherichia coli and related extracellular polysaccharides in other bacteria. Carbohydr. Res. 338:2491-2502.
80. Rahn A, Drummelsmith J, Whitfield C. 1999. Conserved organization in the cps gene clusters for expression of Escherichia coli group 1 K antigens: relationship to the colanic acid biosynthesis locus and the cps genes from Klebsiella pneumoniae. J. Bacteriol. 181:2307-2313.
81. Gunn BM, Wanda SY, Burshell D, Wang C, Curtiss R, III. 2010. Construction of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine vector strains for safety in newborn and infant mice. Clin. Vaccine Immunol. 17:354-362.
82. Stocker BA. 1988. Auxotrophic Salmonella typhi as live vaccine. Vaccine 6:141-145.
83. Stocker BA. 2000. Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. J. Biotechnol. 83:45-50.
84. Kang HY, Srinivasan J, Curtiss R, III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749.
85. Juarez-Rodriguez MD, Yang J, Kader R, Alamuri P, Curtiss R, III, Clark-Curtiss JE. 2012. Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis. Infect. Immun. 80:815-831.
86. + T cell clones. Semin. Immunol. 5:421-430.
87. Gor DO, Rose NR, Greenspan NS. 2003. TH1-TH2: a procrustean paradigm. Nat. Immunol. 4:503-505.
88. Pascual DW, Hone DM, Hall S, van Ginkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, Vancott JL, Kiyono H, McGhee JR. 1999. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect. Immun. 67:6249-6256.
89. Pashine A, John B, Rath S, George A, Bal V. 1999. Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence. Int. Immunol. 11:481-489.
90. Ramarathinam L, Niesel DW, Klimpel GR. 1993. Salmonella typhimurium induces IFN-γ production in murine splenocytes. Role of natural killer cells and macrophages. J. Immunol. 150:3973-3981.
91. Sestini P, Nencioni L, Villa L, Boraschi D, Tagliabue A. 1988. IgAdriven antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes. Am. Rev. Respir. Dis. 137:138-143.
92. Mouslim C, Delgado M, Groisman EA. 2004. Activation of the RcsC/YojN/RcsB phosphorelay system attenuates Salmonella virulence. Mol. Microbiol. 54:386-395.
93. Firozi P, Zhang W, Chen L, Quiocho FA, Worley KC, Templeton NS. 2010. Identification and removal of colanic acid from plasmid DNA preparations: implications for gene therapy. Gene Ther. 17:1484-1499.
94. Pul U, Wurm R, Lux B, Meltzer M, Menzel A, Wagner R. 2005. LRP and H-NS-cooperative partners for transcription regulation at Escherichia coli rRNA promoters. Mol. Microbiol. 58:864-876.
95. Singh AB, Sharma AK, Mukherjee KJ. 2012. Analyzing the metabolic stress response of recombinant Escherichia coli cultures expressing human interferon-beta in high cell density fed batch cultures using time course transcriptomic data. Mol. Biosyst. 8:615-628.
96. Allen PM, Fisher D, Saunders JR, Hart CA. 1987. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanicacid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing. J. Med. Microbiol. 24:363-370.
97. Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer L. 2005. Mucosal immunology, 3rd ed. Elsevier Academic Press, Amsterdam, The Netherlands.
98. Cha HR, Ko HJ, Kim ED, Chang SY, Seo SU, Cuburu N, Ryu S, Kim S, Kweon MN. 2011. Mucosa-associated epithelial chemokine/CCL28 expression in the uterus attracts CCR10+ IgA plasma cells following mucosal vaccination via estrogen control. J. Immunol. 187:3044-3052.
99. Brinkman AB, Ettema TJ, de Vos WM, van der Oost J. 2003. The Lrp family of transcriptional regulators. Mol. Microbiol. 48:287-294.
100. Wang S, Kong Q, Curtiss R, III. 2013. New technologies in developing recombinant attenuated Salmonella vaccine vectors. Microb. Pathog. 58:17-28.
101. Santos SB, Kropinski AM, Ceyssens PJ, Ackermann HW, Villegas A, Lavigne R, Krylov VN, Carvalho CM, Ferreira EC, Azeredo J. 2011. Genomic and proteomic characterization of the broad-host-range Salmonella phage PVP-SE1: creation of a new phage genus. J. Virol. 85:11265-11273.
102. Sutherland IW, Wilkinson JF. 1965. Depolymerases for bacterial exopolysaccharides obtained from phage-infected bacteria. J. Gen. Microbiol. 39:373-383.
103. Qimron U, Marintcheva B, Tabor S, Richardson CC. 2006. Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage. Proc. Natl. Acad. Sci. U. S. A. 103:19039-19044.
104. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Nat. Biotechnol. 6:693-697.
105. Roland K, Curtiss R, III, Sizemore D. 1999. Construction and evaluation of a Δcya Δcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 43:429-441.
106. Edwards RA, Keller LH, Schifferli DM. 1998. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207:149-157.